Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Civitas Therapeutics

Request full access

A privately-held biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically-proven ARCUS dry powder pulmonary delivery platform

Chelsea, United StatesFounded 2009Biotech & Life Sciences

At a glance

Status
Operational
Employees
171
Open positions
None listed
Dealroom signal
23.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Aug 2014 $55M $220M Wellington Management · Fountain Healthcare Partners · Canaan · Longitude Capital —
SERIES BOther financing Sep 2013 $38M $152M Fountain Healthcare Partners · Canaan · Alkermes · Longitude Capital —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Civitas Therapeutics website traffic

Latest recorded traffic for Civitas Therapeutics is 60 monthly website visits. Civitas Therapeutics's team declined 3.4% over the past year.

Latest monthly visits60 1-year team growth-3.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Civitas Therapeutics in the Chelsea ecosystem

Live from Dealroom

The Civitas Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later5 investors entered at this stage

Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Chelsea HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Civitas Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Civitas Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.